Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2…

Overview of attention for article published in BMC Cancer, February 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 72 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 11,473 followers.

RT @LeedsRTresearch: Some results from stage 1 of the SCALOP-2 trial out. Optimising chemoradiation treatments for locally advanced pancrea…

25 Feb 2019

Reply Repost Favourite

RT @LeedsRTresearch: Some results from stage 1 of the SCALOP-2 trial out. Optimising chemoradiation treatments for locally advanced pancrea…

21 Feb 2019

Reply Repost Favourite

Some results from stage 1 of the SCALOP-2 trial out. Optimising chemoradiation treatments for locally advanced pancreatic cancer + assessing benefit of nelfinavir as a radiosensitiser. @MontefioreD @The_OIRO @ChristieLibrary https://t.co/81xan7Z8PX #radonc

21 Feb 2019

Reply Repost Favourite

New from #CR_UK https://t.co/TFTr6EpXRP Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)

11 Feb 2019

Reply Repost Favourite

Study protocol: a multi-centre randomised study of induction #chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose #radiotherapy for locally advanced pancreatic cancer (SCALOP-2) https://t.co/rAa0cJVpOb #PancreaticCancer #Cance

07 Feb 2019

Reply Repost Favourite